BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23076500)

  • 1. Glutamine suppresses DNFB-induced contact dermatitis by deactivating p38 mitogen-activated protein kinase via induction of MAPK phosphatase-1.
    Ayush O; Lee CH; Kim HK; Im SY; Cho BH; Lee HK
    J Invest Dermatol; 2013 Mar; 133(3):723-731. PubMed ID: 23076500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine protects mice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1.
    Ko HM; Oh SH; Bang HS; Kang NI; Cho BH; Im SY; Lee HK
    J Immunol; 2009 Jun; 182(12):7957-62. PubMed ID: 19494320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine up-regulates MAPK phosphatase-1 induction via activation of Ca
    Ayush O; Jin ZW; Kim HK; Shin YR; Im SY; Lee HK
    Biochem Biophys Rep; 2016 Sep; 7():10-19. PubMed ID: 28955885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of glutamine inhibition of cytosolic phospholipase a2 (cPLA2 ): Evidence of physical interaction between glutamine-Induced mitogen-activated protein kinase phosphatase-1 and cPLA2.
    Lee CH; Kim HK; Jeong JS; Lee YD; Jin ZW; Im SY; Lee HK
    Clin Exp Immunol; 2015 Jun; 180(3):571-80. PubMed ID: 25599677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine Prevents Late-Phase Anaphylaxis via MAPK Phosphatase 1-Dependent Cytosolic Phospholipase A2 Deactivation.
    Kim HK; Song CH; Bae YS; Im SY; Lee HK
    Int Arch Allergy Immunol; 2016; 171(1):61-70. PubMed ID: 27838690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine suppresses airway neutrophilia by blocking cytosolic phospholipase A(2) via an induction of MAPK phosphatase-1.
    Lee CH; Kim HK; Kim JM; Ayush O; Im SY; Oh DK; Lee HK
    J Immunol; 2012 Dec; 189(11):5139-46. PubMed ID: 23109722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation.
    Kim JM; Im YN; Chung YJ; Youm JH; Im SY; Han MK; Lee HK
    Allergy; 2022 Apr; 77(4):1180-1191. PubMed ID: 34601745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNFB activates MAPKs and upregulates CD40 in skin-derived dendritic cells.
    Matos TJ; Duarte CB; Gonçalo M; Lopes MC
    J Dermatol Sci; 2005 Aug; 39(2):113-23. PubMed ID: 15896946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
    Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
    Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. l-Glutamine Attenuates DSS-Induced Colitis via Induction of MAPK Phosphatase-1.
    Jeong SY; Im YN; Youm JY; Lee HK; Im SY
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29494494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase phosphatase-1 negatively regulates the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in A549 human lung epithelial cells.
    Turpeinen T; Nieminen R; Moilanen E; Korhonen R
    J Pharmacol Exp Ther; 2010 Apr; 333(1):310-8. PubMed ID: 20089808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of mitogen-activated protein kinase phosphatase-1 (MKP-1) in thyrotropin-releasing hormone (TRH)-induced prolactin gene expression.
    Oride A; Kanasaki H; Purwana IN; Miyazaki K
    Biochem Biophys Res Commun; 2009 May; 382(4):663-7. PubMed ID: 19289102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamine suppresses dinitrophenol fluorobenzene-induced allergic contact dermatitis and itching: inhibition of contact dermatitis by glutamine.
    Jin ZW; Kim HK; Lee CH; Jung SW; Shin SJ; Im SY; Cho BH; Lee HK
    J Dermatol Sci; 2012 Aug; 67(2):88-94. PubMed ID: 22727501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocodazole increases the ERK activity to enhance MKP-1expression which inhibits p38 activation induced by TNF-α.
    Guo X; Zhang X; Li Y; Guo Y; Wang J; Li Y; Shen B; Sun D; Zhang J
    Mol Cell Biochem; 2012 May; 364(1-2):373-80. PubMed ID: 22294037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross talk between p38MAPK and ERK is mediated through MAPK-mediated protein phosphatase 2A catalytic subunit α and MAPK phosphatase-1 expression in human leukemia U937 cells.
    Liu WH; Chen YJ; Cheng TL; Lin SR; Chang LS
    Cell Signal; 2013 Sep; 25(9):1845-51. PubMed ID: 23707387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of oxidative stress in ERK and p38 MAPK activation induced by the chemical sensitizer DNFB in a fetal skin dendritic cell line.
    Matos TJ; Duarte CB; Gonçalo M; Lopes MC
    Immunol Cell Biol; 2005 Dec; 83(6):607-14. PubMed ID: 16266312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
    Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.